Polydextrose (Soluble Glucose-Polymer Fiber)
Polydextrose is a soluble fiber made by bonding glucose with a little sorbitol and citric acid into a branched polymer that resists digestion. It supplies about 1 calorie per gram and is used mainly as a sugar replacer and fiber source in foods; Litesse is one brand of the ingredient. Part of it is fermented by colon bacteria. In healthy adults, 20 g a day for 10 days increased stool weight and frequency. In two trials in people with constipation, 4 to 12 g a day did not shorten transit time, the main outcome, though some bowel movement or symptom scores improved versus placebo; EU regulators did not accept a bowel function claim. Single-day tests, mostly maker-funded, found lower calorie intake at the next meal, but a 15-day trial found no change in intake and 12 g a day for 6 months did not change body fat. Adding it to a drink or bar did not lower blood sugar. Very large intakes loosen stools.
Benefits
Stool bulk and bowel movement frequency
In 36 healthy adults, 20 g a day for 10 days increased stool weight and frequency and softened stools versus a low-fiber control; EU regulators noted two longer trials at 18 and 21 g a day that did not. In adults with constipation, neither of two trials shortened transit time, the main outcome; 12 g a day gave more weekly bowel movements than placebo in a maker-run trial, and 8 g a day improved rectal and stool symptom scores in another.
Gut bacteria changes in healthy adults
In a maker-funded study in healthy adults, 8 g a day raised butyrate-producing bacteria, and less abdominal discomfort was recorded. In another, 21 g a day for three weeks raised Faecalibacterium prausnitzii and related groups compared with no added fiber. These are changes in stool bacteria, not measured health outcomes.
Satiety and calorie intake at the next meal
In single-day tests, mostly funded by the maker, a drink or snack with polydextrose cut calories eaten at the next meal, and larger doses cut more. A maker-authored pooled analysis found no reliable drop over the whole day, a 15-day trial in overweight adults and a single-day trial in women found no change, and 12 g a day for 6 months did not change body fat or food intake.
Hunger and appetite ratings after a snack or meal
Pooled ratings from seven studies, five of them sponsored at least in part by the maker, showed only a small drop in desire to eat while eating; hunger, fullness and satisfaction did not change overall. In 18 adults with obesity, 15 g with a high-fat meal lowered hunger afterward by 40% and raised the gut hormone GLP-1. Other trials found no change in appetite ratings.
Post-meal blood sugar and insulin when it replaces sugar or starch
In 18 overweight adults, swapping 30% of the available carbohydrate at breakfast and lunch for polydextrose lowered the insulin rise after both meals compared with the full-carbohydrate diet, but the lower glucose peak was not significant and overnight glucose was higher. Adding 8 to 16 g to a drink or bar did not lower post-meal glucose or insulin in healthy adults, and at 12 g glucose rose more.
Mechanism of action
Resists digestion and is slowly fermented
Its random, branched glucose bonds resist human digestive enzymes, so little is absorbed. Part of it reaches the large intestine and is fermented there into short-chain fatty acids. It is counted at about 1 calorie per gram.
Adds stool bulk and lowers stool pH
Part of polydextrose is fermented in the colon, and the rest passes through. In healthy adults eating 20 g a day, stool weight rose, stools were softer and stool pH fell compared with a low-fiber diet, while whole-gut transit time did not change.
Gut hormone signals linked to fullness
In two maker-run human trials, polydextrose with a meal raised the gut hormone GLP-1, which signals fullness. Ghrelin, CCK and PYY did not change, so how it affects appetite is not fully explained.
Displaces digestible carbohydrate
Because little of it is absorbed as glucose, using polydextrose in place of sugar or starch lowers the usable carbohydrate and calories in a food. When it replaced part of the carbohydrate in meals, the insulin rise was lower than with the full-carbohydrate meals; simply adding it to a drink or bar did not lower post-meal blood sugar.
Clinical trials
Randomized within-subject crossover trial of an 837 kJ liquid preload containing 0, 6.3, 12.5 or 25 g polydextrose (Litesse Ultra, per a later review), with an ad libitum test meal 90 minutes later and food diaries for the rest of the day; sponsored by the UK BBSRC with Mars UK as a private partner, per that review (Astbury et al. 2013, Br J Nutr).
21 adults (12 men, 9 women).
Test-meal calorie intake was lower after every polydextrose dose than after the control, falling from 5,756 kJ to 4,362 kJ at 25 g. Intake for the rest of the day did not differ, and total daily intake was lower after 12.5 and 25 g. Appetite ratings did not differ, and each test lasted a single day.
Acute, randomized, double-blind, placebo-controlled crossover trial of 12.5 g polydextrose given with breakfast or as a mid-morning preload, with DuPont-affiliated authors (Ibarra et al. 2017, Appetite).
32 healthy normal-weight and overweight women.
Polydextrose did not change later calorie intake, the primary outcome. Mid-morning polydextrose lowered hunger by 31% during the satiation period; with breakfast it lowered insulin by about 16% and raised GLP-1 by about 40%. Other appetite ratings and gastric emptying did not change.
Single-blind randomized crossover trial of a mid-morning cereal bar with 16.7 g polydextrose versus an energy-matched control bar for 15 days each, with a 15-day washout (Martinelli et al. 2018, Int J Food Sci Nutr).
Overweight adults.
Calorie intake at lunch, for the rest of the day and for the whole day, and appetite ratings, did not differ between the polydextrose and control bars on day 1 or day 15.
Randomized, double-blind, placebo-controlled crossover trial of 20 g/day polydextrose or soluble corn fiber in a muffin and cereal versus a low-fiber control, 10 days per period (Timm et al. 2013, J Nutr).
36 healthy men and women.
Polydextrose increased 5-day fecal wet weight, stools per day and daily fecal output, and gave softer stools than control. Whole-gut transit time did not change. Flatulence and stomach rumbling were reported more often with polydextrose.
Randomized, double-blind, placebo-controlled trial of 8 or 12 g/day polydextrose for 4 weeks, with transit time measured by radiopaque markers; funded by Nestec SA (Nestle), with most authors Nestec employees (Duncan et al. 2018, Nutrients).
128 adults with chronic constipation.
Transit time did not shorten at 2 weeks in any group, and stool frequency and consistency did not improve at 2 or 4 weeks; at 12 g/day, transit through the left colon was slower than with placebo (p = 0.01). Versus placebo, 8 g/day improved the questionnaire rectal symptom score at 2 and 4 weeks and the stool symptom score at 4 weeks. Adverse events did not differ between groups.
Double-blind, randomized, placebo-controlled trial of Litesse Ultra at 4, 8 or 12 g/day versus 12 g maltodextrin for 2 weeks after a 2-week run-in, with colonic transit time as the primary outcome; fully sponsored by DuPont Nutrition and Health, two authors were DuPont employees and three were employees of KGK Synergize, the research firm DuPont hired to run it (Ibarra et al. 2019, Nutrients).
192 adults with functional constipation by Rome III criteria (baseline transit 42 hours and 8.7 bowel movements a week).
Colonic transit time did not differ between groups, and the authors state the group was not constipated enough at baseline. At 12 g/day, weekly bowel movements were higher than with placebo (Dunnett-adjusted p = 0.006), but the 12 g group rose by only 1.1 a week from run-in (not significant) while the placebo group fell by 1.0 a week. Most questionnaire scores improved from baseline in all groups, including placebo; the 4 g/day group reported 65% worse rectal symptom scores than placebo (Dunnett-adjusted p = 0.027). No serious adverse events were reported.
Double-blind, placebo-controlled crossover human feeding study of 8 g/day polydextrose; funded by Danisco, which markets polydextrose, and five authors were Danisco employees (Costabile et al. 2012, Br J Nutr).
Healthy adults.
Polydextrose raised the butyrate producer Ruminococcus intestinalis and Clostridium clusters I, II and IV and lowered the Lactobacillus-Enterococcus group. Participants recorded less abdominal discomfort, with a trend toward fewer hard stools. Bacterial shifts are lab measures, not health outcomes.
Two controlled, randomized, single-blinded crossover trials testing 0, 8, 12 or 16 g polydextrose in a drink and 0 or 12 g in a bar; Europe PMC lists US FDA funding (an IIT/FDA research agreement and grant U19 FD005322) (Rahman et al. 2017, J Food Sci).
34 healthy adults (drink) and 19 healthy adults (bar).
Polydextrose did not lower post-meal glucose or insulin in either the drink or the bar. At 12 g, glucose rose more than without polydextrose in both foods, and insulin rose more with the bar. The authors report it was well tolerated at all doses tested.
Randomized, double-blind, placebo-controlled, four-arm parallel trial of 12 g/day Litesse Ultra polydextrose, the probiotic Bifidobacterium animalis subsp. lactis 420 (B420), both together, or a cellulose placebo for 6 months, with body fat measured by DXA; fully funded by DuPont Nutrition and Health, with DuPont authors (Stenman et al. 2016, EBioMedicine).
225 healthy adults with overweight or obesity (BMI 28 to 34.9).
Polydextrose alone did not change body fat mass compared with placebo (+0.3%, P = 1.00, per-protocol), and the authors report it had no effect on the measured outcomes, including food intake. B420 plus polydextrose lowered body fat versus placebo only in the per-protocol analysis (B420 alone did not, P = 0.28 in the main comparison; only a post-hoc factorial analysis pooling both B420 groups against the groups without B420 was significant); no group differed in the intention-to-treat analysis. Adverse events did not differ between groups.
Side effects and drug interactions
Common Potential side effects
Important Drug interactions
Frequently asked questions about Polydextrose (Soluble Glucose-Polymer Fiber)
What is polydextrose and where is it found?
Polydextrose is a soluble fiber made mostly from glucose, with a little sorbitol and citric acid, bonded into a branched polymer your enzymes cannot easily break down. It supplies about 1 calorie per gram and is used to add fiber and bulk to reduced-sugar foods, drinks and fiber supplements. Litesse is one well-known brand of the ingredient.
Does polydextrose help you eat less?
In single-day lab tests, mostly funded by the maker, a snack or drink containing 6 to 25 g lowered how much people ate at the next meal. A pooled analysis found no reliable drop over the whole day, a 15-day trial in overweight adults found no change, and in a 6-month trial 12 g a day did not reduce body fat.
Will polydextrose help with regularity?
In healthy adults, 20 g a day for 10 days increased stool weight and frequency. In people with constipation, neither of two trials shortened transit time, the main outcome; a maker-run trial found more weekly bowel movements at 12 g a day than placebo, and another found better rectal and stool symptom scores at 8 g a day without more frequent stools. EU regulators did not accept a bowel function claim.
How much polydextrose is too much?
JECFA and the EU SCF set a mean laxative threshold of about 90 g a day, or about 50 g taken at once; EFSA agreed, noted that sensitivity varies between people, and saw no need for a numerical acceptable daily intake. US rules require foods with more than 15 g per serving to warn that sensitive people may get a laxative effect. In one trial, gas and stomach rumbling were more common at 20 g a day.
Does polydextrose count as dietary fiber on US labels?
FDA lists polydextrose among the added fibers it intends to propose adding to its dietary fiber definition. Until that rulemaking is done, FDA says it will exercise enforcement discretion, so makers can count it as dietary fiber on Nutrition and Supplement Facts labels and use a caloric value of 1 kcal per gram.
What is Polydextrose?
Polydextrose is a soluble fiber made by bonding glucose with a little sorbitol and citric acid into a branched polymer that resists digestion. It supplies about 1 calorie per gram and is used mainly as a sugar replacer and fiber source in foods; Litesse is one brand of the ingredient.
What is Polydextrose used for?
Polydextrose is researched primarily for Gut Health. In 36 healthy adults, 20 g a day for 10 days increased stool weight and frequency and softened stools versus a low-fiber control; EU regulators noted two longer trials at 18 and 21 g a day that did not.
What is the recommended dosage of Polydextrose?
The clinically studied dose is Appetite tests used 6.3 to 25 g in a single snack, drink or meal; a body fat trial used 12 g/day for 6 months. Bowel trials used 4 to 12 g/day for 2 to 4 weeks and 20 g/day for 10 days; gut bacteria studies used 8 and 21 g/day. Always follow the product label and check with a healthcare provider for personal advice.
Is Polydextrose safe, and does it have side effects?
Side effects and cautions reported for Polydextrose include: Flatulence and stomach rumbling were reported more often at 20 g/day than with a low-fiber control in a 10-day trial. Very large amounts loosen stools: JECFA and the EU SCF set a mean laxative threshold of about 90 g/day, or 50 g taken at once, which EFSA accepted while noting th… It may also interact with some medications. Polydextrose is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.
Does Polydextrose interact with any medications?
Possible interactions include: No drug interactions have been established for polydextrose in the trials cited here, which enrolled mostly healthy adults. Fiber can change how quickly some medicines are absorbed; as a general precaution, take medicines an hour or two apart from a large fiber dose. If you take prescription medication, check with a pharmacist or doctor before using it.
How strong is the scientific evidence for Polydextrose?
NutraSmarts rates the evidence for Polydextrose as Limited (2 out of 5). It is backed by 9 study summaries and 19 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.
References(19 citations)
Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.
- Effects of polydextrose on different levels of energy intake. A systematic review and meta-analysis. Appetite. 2015;87:30-7. doi: 10.1016/j.appet.2014.12.099.PubMedUsed to support: Systematic review and meta-analysis by authors from DuPont, the maker of Litesse polydextrose. All included studies gave polydextrose in a mid-morning snack. Across six studies, energy intake at an ad libitum lunch was lower after polydextrose (SMD 0.35), and the drop grew with dose (about 0.67% less per gram). Intake over the rest of the day and total daily intake did not differ significantly in the pooled analysis, although a dose regression suggested a small dose-related drop in daily intake (about 0.35% per gram).
- Effect of Polydextrose on Subjective Feelings of Appetite during the Satiation and Satiety Periods: A Systematic Review and Meta-Analysis. Nutrients. 2016;8(1):45. doi: 10.3390/nu8010045.PubMedUsed to support: Meta-analysis of seven appetite studies by the same DuPont-affiliated group; the full text states that all included studies used Litesse Ultra or Litesse Two, that the Astbury studies were sponsored by the UK BBSRC with Mars UK, and that all others were sponsored at least in part by DuPont. Only desire to eat during the satiation (eating) period was lower with polydextrose (SMD 0.24); hunger, fullness, satisfaction and prospective consumption did not differ.
- Polydextrose results in a dose-dependent reduction in ad libitum energy intake at a subsequent test meal. Br J Nutr. 2013;110(5):934-42. doi: 10.1017/S0007114512005776.PubMedUsed to support: Randomized crossover study in 21 adults: an 837 kJ liquid preload with 6.3, 12.5 or 25 g polydextrose lowered intake at a test meal 90 minutes later versus a 0 g control (5,756 kJ on control vs 4,362 kJ at 25 g). Self-reported intake for the rest of the day did not differ, and total daily intake was lower after the 12.5 and 25 g preloads. Appetite ratings did not differ between preloads. A later review identifies the product as Litesse Ultra and the sponsor as the UK BBSRC with Mars UK.
- Effects of polydextrose with breakfast or with a midmorning preload on food intake and other appetite-related parameters in healthy normal-weight and overweight females: An acute, randomized, double-blind, placebo-controlled, and crossover study. Appetite. 2017;110:15-24. doi: 10.1016/j.appet.2016.12.002.PubMedUsed to support: Double-blind, placebo-controlled crossover trial in 32 normal-weight and overweight women, with DuPont-affiliated authors: 12.5 g polydextrose with breakfast or mid-morning did not change later energy intake (the primary outcome). Mid-morning polydextrose lowered hunger during the satiation period by 31%; with breakfast it lowered insulin by about 16% and raised GLP-1 by about 40%, with no change in gastric emptying.
- Effects of cereal bar containing polydextrose on subjective feelings of appetite and energy intake in overweight adults over 15 d. Int J Food Sci Nutr. 2018;69(7):892-899. doi: 10.1080/09637486.2018.1426738.PubMedUsed to support: Single-blind randomized crossover trial in overweight adults: a mid-morning cereal bar with 16.7 g polydextrose for 15 days did not change energy intake (at lunch, rest of day or total) or appetite ratings compared with an energy-matched control bar.
- Postprandial effects of polydextrose on satiety hormone responses and subjective feelings of appetite in obese participants. Nutr J. 2015;14:2. doi: 10.1186/1475-2891-14-2.PubMedUsed to support: Double-blind, placebo-controlled crossover trial in 18 non-diabetic adults with obesity, led by DuPont authors: 15 g polydextrose added to a high-fat meal raised post-meal GLP-1 more than placebo and reduced hunger after the meal by 40%. Ghrelin, CCK and PYY responses did not differ.
- Effect of polydextrose and soluble maize fibre on energy metabolism, metabolic profile and appetite control in overweight men and women. Br J Nutr. 2014;111(1):111-21. doi: 10.1017/S0007114513002183.PubMedUsed to support: Single-blind randomized crossover study in 18 overweight adults in a respiration chamber, supported by Tate and Lyle, which provided the test products: replacing 30% of the available carbohydrate at breakfast and lunch with polydextrose lowered the insulin response after both meals versus the full-carbohydrate control, while the lower peak glucose after breakfast was not significant (P = 0.06) and overnight glucose was highest on polydextrose. Desire to eat and hunger over 24 hours were lower than with both control diets. A rise in 24-hour fat oxidation was attributed mainly to the lower energy content of the fiber diets.
- Polydextrose and soluble corn fiber increase five-day fecal wet weight in healthy men and women. J Nutr. 2013;143(4):473-8. doi: 10.3945/jn.112.170118.PubMedUsed to support: Double-blind, placebo-controlled crossover trial in 36 healthy adults: 20 g/day polydextrose in a muffin and cereal for 10 days increased fecal wet weight, stools per day and daily fecal output and gave softer stools than a low-fiber control, without changing whole-gut transit time. Flatulence and stomach rumbling were reported more often.
- Short-Term Daily Intake of Polydextrose Fiber Does Not Shorten Intestinal Transit Time in Constipated Adults: A Randomized Controlled Trial. Nutrients. 2018;10(7):920. doi: 10.3390/nu10070920.PubMedUsed to support: Randomized, double-blind, placebo-controlled trial in 128 adults with chronic constipation, funded by Nestle, with most authors employed by Nestle: 8 or 12 g/day polydextrose for 4 weeks did not shorten transit time at 2 weeks (the primary outcome) and did not improve stool frequency or consistency at 2 or 4 weeks; left colon transit was slower with 12 g/day than with placebo. Some questionnaire symptom scores improved, mainly at 8 g/day.
- Efficacy of Polydextrose Supplementation on Colonic Transit Time, Bowel Movements, and Gastrointestinal Symptoms in Adults: A Double-Blind, Randomized, Placebo-Controlled Trial. Nutrients. 2019;11(2):439. doi: 10.3390/nu11020439.PubMedUsed to support: Double-blind, placebo-controlled trial in 192 adults with functional constipation, fully sponsored by DuPont Nutrition and Health (maker of Litesse Ultra), with two DuPont authors and three authors from KGK Synergize, the firm DuPont hired to run it: 4, 8 or 12 g/day for 2 weeks did not change colonic transit time, the primary outcome, and the authors state participants were not constipated enough at baseline. At 12 g/day, weekly bowel movements were higher than with placebo (Dunnett-adjusted p = 0.006), partly because the placebo group fell by 1.0 a week while the 12 g group rose by 1.1 (not significant within group). The 4 g/day group reported a 65% worse PAC-SYM rectal symptom subscale than placebo (Dunnett-adjusted p = 0.027). No serious adverse events were reported.
- Impact of polydextrose on the faecal microbiota: a double-blind, crossover, placebo-controlled feeding study in healthy human subjects. Br J Nutr. 2012;108(3):471-81. doi: 10.1017/S0007114511005782.PubMedUsed to support: Double-blind, placebo-controlled crossover feeding study in healthy adults, funded by Danisco, which markets polydextrose, with five authors employed by Danisco: 8 g/day polydextrose raised the butyrate producer Ruminococcus intestinalis and Clostridium clusters I, II and IV and lowered the Lactobacillus-Enterococcus group. It was fermented slowly, and participants recorded less abdominal discomfort and a trend toward fewer hard stools.
- 454 pyrosequencing reveals a shift in fecal microbiota of healthy adult men consuming polydextrose or soluble corn fiber. J Nutr. 2012;142(7):1259-65. doi: 10.3945/jn.112.158766.PubMedUsed to support: Randomized, double-blind, placebo-controlled crossover study in 20 healthy men eating about 14 g/day of fiber: 21 g/day polydextrose in snack bars for 21 days raised fecal Faecalibacterium (including F. prausnitzii), Phascolarctobacterium and Dialister compared with no added fiber.
- A Randomized, Controlled Trial Evaluating Polydextrose as a Fiber in a Wet and Dry Matrix on Glycemic Control. J Food Sci. 2017;82(10):2471-2478. doi: 10.1111/1750-3841.13855.PubMedUsed to support: Two controlled, randomized, single-blinded crossover trials in healthy adults (34 with a drink at 0, 8, 12 or 16 g polydextrose; 19 with a bar at 0 or 12 g); Europe PMC lists US FDA funding (an IIT/FDA research agreement and grant U19 FD005322). Polydextrose did not lower post-meal glucose or insulin in either food form; at 12 g, glucose was higher in both forms and insulin was higher with the bar. The authors report it was well tolerated at all doses.
- A review of the clinical toleration studies of polydextrose in food. Food Chem Toxicol. 2004;42(9):1531-42. doi: 10.1016/j.fct.2004.04.015.PubMedUsed to support: Review of nine clinical studies of polydextrose that measured laxation endpoints in adults and children: polydextrose (a non-digestible 1 kcal/g polysaccharide) was better tolerated than most other low-digestible carbohydrates such as polyols, which the authors attribute to its higher molecular weight and partial colonic fermentation. JECFA and the European Commission Scientific Committee for Food concluded that it has a mean laxative threshold of about 90 g/day (1.3 g/kg body weight) or 50 g as a single dose.
- Re-evaluation of polydextrose (E 1200) as a food additive. EFSA J. 2021;19(1):e06363. doi: 10.2903/j.efsa.2021.6363.PubMedUsed to support: EU safety re-evaluation of the food additive E 1200: polydextrose consists of about 90 parts glucose, 10 parts sorbitol and 1 part citric acid (or 0.1 part phosphoric acid); its absorption is limited and part of it is fermented in the large intestine into short-chain fatty acids. No adverse effects were found in long-term animal studies at the highest doses tested, and the Panel saw no need for a numerical acceptable daily intake and no safety concern at reported use levels. The full text agrees with the JECFA and SCF mean laxative threshold of 90 g per person per day or 50 g as a single dose, while noting that sensitivity varies between people.
- Polydextrose and maintenance of normal defecation: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006. EFSA J. 2016;14(5):e04480. doi: 10.2903/j.efsa.2016.4480.PubMedUsed to support: EU scientific opinion on a claim applied for by Tate & Lyle: of three usable human studies, one showed an effect on bowel function at 20 g/day for 10 days, while two at 21 and 18 g/day over longer periods did not, and evidence for a mechanism in humans was weak. The Panel concluded that a cause and effect relationship between polydextrose and maintenance of normal defecation had not been established.
- Probiotic With or Without Fiber Controls Body Fat Mass, Associated With Serum Zonulin, in Overweight and Obese Adults-Randomized Controlled Trial. EBioMedicine. 2016;13:190-200. doi: 10.1016/j.ebiom.2016.10.036.PubMedUsed to support: Six-month randomized, double-blind, placebo-controlled trial in 225 adults with overweight or obesity (BMI 28 to 34.9), fully funded by DuPont Nutrition and Health, with DuPont authors: 12 g/day Litesse Ultra polydextrose alone did not change body fat mass versus placebo (+0.3%, P = 1.00, per-protocol) and had no effect on the measured outcomes, including food intake. Polydextrose plus B420 lowered body fat versus placebo in the per-protocol analysis only (-4.5%, P = 0.02); B420 alone did not (-3.0%, P = 0.28); only a post-hoc factorial analysis pooling both B420 groups against the groups without B420 was significant. No group differed in body fat in the intention-to-treat analysis, and adverse events did not differ between groups.
- 21 CFR 172.841 Polydextrose. Electronic Code of Federal Regulations (eCFR). 2026;Title 21, Part 172, Subpart I, Section 172.841..SourceUsed to support: Not PubMed-indexed. US food additive regulation: polydextrose is made from a melt of about 89 percent glucose, 10 percent sorbitol and 1 percent citric acid (or about 90 percent glucose, 10 percent sorbitol and 0.1 percent phosphoric acid) and may be used as a bulking agent, formulation aid, humectant and texturizer in all foods except meat and poultry, baby food and infant formula. Foods where a single serving would be expected to exceed 15 g must state that sensitive individuals may experience a laxative effect from excessive consumption.
- Questions and Answers on Dietary Fiber. FDA website. 2026;Web page, Nutrition, Food Labeling, and Critical Foods..SourceUsed to support: Not PubMed-indexed. FDA lists polydextrose among the non-digestible carbohydrates it intends to propose adding to the regulatory definition of dietary fiber, and states it will exercise enforcement discretion for declaring these fibers on Nutrition and Supplement Facts labels and for a caloric value for polydextrose of 1 kcal/g, pending rulemaking.